Introduction: Extra pulmonary neuroendocrine carcinomas(EPNEC) are rare tumours, this implies lack of knowledge on the burden.
Aim(s): With this study we aim to analyse the incidence, relative survival(RS) and treatment for EPNEC patients in the Netherlands.
Materials and methods: Patients diagnosed with EPNEC and NEC with unknown primary(UP) were included from the Netherlands cancer registry between 2008-2012. Correctness checks on this data were conducted by linkage to the archived pathology report. Incidence was analysed using the European Standardized Rate(ESR). For treatment we assigned patients to the hospital that set the treatment plan. RS was calculated using the Ederer II method.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: MSc. Jan Maarten Van Der Zwan
To read results and conclusion, please login ...
Further abstracts you may be interested in